Business ❯Finance ❯Stock Market ❯Public Companies

Moderna

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

Moderna Reports Unexpected Profit on Strong COVID Vaccine Sales